Biosimilars Council appeals to Supreme Court for lower drug prices
The Biosimilars Council is hoping the Supreme Court will acknowledge the savings that biosimilar medications can offer to both patients and health systems. Read More »
The Biosimilars Council is hoping the Supreme Court will acknowledge the savings that biosimilar medications can offer to both patients and health systems. Read More »
U.S. House Judiciary Chairman Bob Goodlatte (R-VA) has sent letters to the American Bar Association and every state bar association, urging the organizations to adopt requirements for warnings on trial lawyer advertisements that urge patients to discontinue the use of some medicines. Read More »
U.S. Congressmen Doug Collins (R-GA) and Dave Loebsack (D-IA) last week introduced a bill -- H.R. 1316, the Prescription Drug Price Transparency Act -- that they say would "require greater transparency from pharmacy benefit managers (PBMs)." In introducing the bill, the congressmen, along with Rep. Buddy Carter (R-GA) and others, took to the House floor to deliver what Drug Channels' Dr. Adam Fein referred to as a "60-minute rant" against PBMs. Read More »
Leaders from the health care continuum met last month in Washington, D.C. to explore methods to enhance payment and delivery methods for the private market to create better value for patients. Read More »
The Pharmaceutical Research and Manufacturers of American (PhRMA) recently sponsored "Through the Microscope: Examining Modern Medicine," its first national health care dialogue series. Read More »
The Pharmaceutical Research and Manufacturers of America submitted comments this month to the 2017 Special 301 Report. Read More »
The Association for Accessible Medicines (AAM) recently announced that its president and CEO, Chip Davis, made a statement regarding the confirmation of Tom Price as Secretary of Health and Human Services. Read More »
Dr. Bernie Zeiher, president of development at Astellas Pharma, recently addressed the use of biomarkers in the development of precise and specific treatments for patients. Read More »
Prime Therapeutics releases report showing it held drug costs increases to just 2.5 percent for its clients in 2015. Read More »
"I'm thankful that we have the PBMs in the Part D program that are performing that negotiation on behalf of seniors." -- Seema Verma, nominee to serve as administrator of the Centers for Medicare and Medicaid Services Read More »
Lifes2good's new Berkeley Life Heart Health supplement, distributed by L2G North America Inc., is now available at Vitamin Shoppe and GNC stores across the country. Read More »
High prescription drug costs mean approximately 45 million adults in the U.S., or 18 percent of Americans over the age of 18, did not fill a prescription last year, according to the nonprofit group Prescription Justice.. Read More »
The newly rebranded Association for Accessible Medicines (AAM) recently launched a nationwide campaign with the mission of 'Keeping Medicines in Reach,' sharing patient profiles and maintaining its vision to control existing drug costs. Read More »
PharmaSmart International, a specialist in blood pressure kiosks, announced that its machines meet new Centers for Disease Control guidelines. Read More »
Soem critics argue that decades of U.S. Food and Drug Administration safeguards could be in jeopardy with President Donald Trump’s pick for head of the FDA. Read More »
The Center for Medicaid and CHIP Services is encouraging pharmacies to extend the scope of dispensing medications to foster immediate access to certain drugs. Read More »
i-Health Inc. is moving toward the acquisition of UP4 Probiotics from UAS Laboratories LLC in an arrangement the company believes will help it become a leader in the probiotic world. Read More »
The recent National Association of Chain Drug Stores Regional Chain Conference in Palm Beach, Florida addressed the important role of pharmacies in this country amid possible changes under President Donald Trump's administration. Read More »
The Advisory Committee on Immunization Practices, an extension of the Centers for Disease Control, recommends not using the live influenza vaccine due to poor efficacy. Read More »
The U.S. House of Representative recently passed legislation that increases the role of pharmacists in patient needs by expanded the services that pharmacies offer. Read More »